These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7694879)

  • 21. Diurnal metabolic profiles in hyperthyroidism.
    McCulloch AJ; Johnston DG; Burrin JM; Hodson AW; Clark F; Waugh C; Alberti KG
    Eur J Clin Invest; 1982 Jun; 12(3):269-76. PubMed ID: 6179780
    [No Abstract]   [Full Text] [Related]  

  • 22. Tacrolimus reversibly reduces insulin secretion in paediatric renal transplant recipients.
    Filler G; Neuschulz I; Vollmer I; Amendt P; Hocher B
    Nephrol Dial Transplant; 2000 Jun; 15(6):867-71. PubMed ID: 10831643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose and leucine metabolism in lung tranplanted patients on low dose of steroids for immunosuppressive therapy.
    Benedini S; Ruffini E; Terruzzi I; Mancuso M; Luzi L
    Transplant Proc; 2008 Jun; 40(5):1566-71. PubMed ID: 18589153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of long-term cyclosporine or FK 506 therapy on glucose and lipid metabolism in stable liver graft recipients.
    Loss M; Winkler M; Schneider A; Brinkmann C; Manns M; Ringe B; Pichlmayr R
    Transplant Proc; 1995 Feb; 27(1):1136-9. PubMed ID: 7533365
    [No Abstract]   [Full Text] [Related]  

  • 25. Glucose and lipid metabolism in liver transplant patients under long-term tacrolimus (FK 506) monotherapy.
    Loss M; Winkler M; Schneider A; Oldhafer K; Manns MP; Pichlmayr R
    Transplant Proc; 1996 Apr; 28(2):1006-7. PubMed ID: 8623210
    [No Abstract]   [Full Text] [Related]  

  • 26. Metabolic changes in active chronic hepatitis.
    Alberti KG; Record CO; Williamson DH; Wright R
    Clin Sci; 1972 May; 42(5):591-605. PubMed ID: 5032890
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients.
    Hohage H; Arlt M; Brückner D; Dietl KH; Zidek W; Spieker C
    Clin Transplant; 1997 Jun; 11(3):225-30. PubMed ID: 9193847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for impaired glucose effectiveness in cirrhotic patients after liver transplantation.
    Konrad T; Steinmüller T; Vicini P; Toffolo G; Grewerus D; Schüller A; Bechstein WO; Usadel KH; Cobelli C; Mahon A; Wittmann W; Klar E; Golling M; Neuhaus P
    Metabolism; 2000 Mar; 49(3):367-72. PubMed ID: 10726916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic effects of monomeric insulin analogues of different receptor affinity.
    Robertson DA; Singh BM; Hale PJ; Jensen I; Nattrass M
    Diabet Med; 1992 Apr; 9(3):240-6. PubMed ID: 1576805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-insulin-dependent diabetes: 10-year outcome in relation to initial response to diet and subsequent sulfonylurea therapy.
    Sönksen PH; Lowy C; Perkins JR; Lim HS
    Diabetes Care; 1984; 7 Suppl 1():59-66. PubMed ID: 6376030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation.
    Fisher RA; Stone JJ; Wolfe LG; Rodgers CM; Anderson ML; Sterling RK; Shiffman ML; Luketic VA; Contos MJ; Mills AS; Ferreira-Gonzalez A; Posner MP
    Clin Transplant; 2004 Aug; 18(4):463-72. PubMed ID: 15233827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tacrolimus and glucose metabolism.
    van Hooff JP; van Duijnhoven EM; Christiaans MH
    Transplant Proc; 1999 Nov; 31(7A):49S-50S. PubMed ID: 10576044
    [No Abstract]   [Full Text] [Related]  

  • 33. Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients.
    Webster A; Woodroffe RC; Taylor RS; Chapman JR; Craig JC
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003961. PubMed ID: 16235347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.
    Penninga L; Penninga EI; Møller CH; Iversen M; Steinbrüchel DA; Gluud C
    Cochrane Database Syst Rev; 2013 May; (5):CD008817. PubMed ID: 23728681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic profiles in patients with insulinoma.
    Hale PJ; Nattrass M
    Clin Endocrinol (Oxf); 1989 Jan; 30(1):29-38. PubMed ID: 2550166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunsuppressive therapy by FK506/tacrolimus.
    Lohmann T; List C; Lamesch P; Kohlhaw K; Wenzke M; Schwarz C; Richter O; Hauss J; Seissler J
    Exp Clin Endocrinol Diabetes; 2000; 108(5):347-52. PubMed ID: 10989953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Rejection of a liver allograft. Diagnosis and treatment].
    Calmus Y
    Ann Radiol (Paris); 1994; 37(5):377-82. PubMed ID: 7527621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The short-term effect of nicotinic acid on intermediary metabolism in insulin-dependent diabetes mellitus.
    Hale PJ; Nattrass M
    Ann Clin Biochem; 1991 Jan; 28 ( Pt 1)():39-43. PubMed ID: 2024932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic effects of a corticosteroid-free immunosuppressive regimen in recipients of pancreatic transplant.
    Luzi L; Picena Sereni L; Battezzati A; Elli A; Soulillou JP; Cantarovich D
    Transplantation; 2003 Jun; 75(12):2018-23. PubMed ID: 12829904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic effects of low-dose incremental insulin infusion in diabetic man.
    Hale PJ; Black E; Nattrass M
    Horm Metab Res; 1986 Feb; 18(2):129-33. PubMed ID: 3516823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.